UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000014299
Receipt No. R000016650
Scientific Title Phase II study of erlotinib monotherapy for patients with advanced stage of non-small cell lung cancer, undetectable epidermal growth factor receptor (EGFR) mutations by PNA LNA PCR clamp method, but positive immuno-staining with anti-EGFR mutation-specific antibodies.
Date of disclosure of the study information 2014/07/01
Last modified on 2016/08/05 13:23:11

No. Disposal Last modified on Item of update
1 Insert 2014/06/18 12:23:01
2 Update 2014/06/18 16:41:40 Recruitment status
3 Update 2014/12/19 09:40:11 Key exclusion criteria
4 Update 2016/08/05 13:23:11 Recruitment status

Contact us.